• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Guidance from Global Regulators Stresses Patient Safety, Risk Assessment

Guidance from Global Regulators Stresses Patient Safety, Risk Assessment

May 18, 2020

Regulators around the world have issued guidance and recommendations on how to navigate clinical trials during the COVID-19 pandemic. Here is a summary of actions some agencies in the southern hemisphere have taken:

  • Mexico’s regulatory authority COFEPRIS recommended in a recent announcement that sponsors operating trials in the country develop a risk-management plan consisting of alternative safety measures to protect patients. Visits for currently enrolled participants may be rescheduled, COFEPRIS said, whereas recruitment of new participants should be postponed. Amendments to trials because of COVID-19 should be implemented immediately and submitted to the agency afterward.
  • Similar to Mexico, Argentina also recommends sponsors develop a risk-management plan that will ensure safety of trial participants. Recruitment of healthy participants should be postponed unless a trial is directly studying COVID-19, said the National Administration of Medicines, Food and Medical Technology in that nation.
  • Colombia has given its National Institute for Food and Drug Surveillance (INVIMA) permission to advance all COVID-19 trials approved by an ethics committee associated with a research center. A guideline for submitting trials to the INVIMA has been posted on the regulator’s website.
  • In South Africa, the Health Products Regulatory Authority (SAHPRA) has issued guidance for clinical trials to help sponsors and CROs ensure the safety of trial participants during the pandemic. SAHPRA also recommends sponsors describe in their clinical study reports how COVID-19 impacted their trials to justify any protocol changes made or gaps in trial data.
COVID-19
  • Related Directories

    Olumiant (baricitinib)

    Veklury (remdesivir)

    Comirnaty (COVID-19 Vaccine, mRNA)

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing